Cypryk Katarzyna, Pertyńska-Marczewska Magdalena, Szymczak Wiesław, Zawodniak-Szałapska Małgorzata, Wilczyński Jan, Lewiński Andrzej
Klinika Endokrynologii i Terapii Izotopowej, Uniwersytetu Medycznego, Instytut Centrum Zdrowia Matki Polki w Lodzi.
Przegl Lek. 2005;62(1):38-41.
Gestational diabetes mellitus (GDM) affects about 5% of all pregnancies and results in an increased incidence of Caesarean sections, perinatal traumas and neonatal complications. Macrosomy, i.e., an excessive birth-weight is observed in newborns from these pregnancies. In the majority of cases, diabetes regression is observed directly after pregnancy termination, however, in 15-60% of these patients, diabetes mellitus develops in later years of life. The goal of the study was an assessment of the risk factors for GDM development in gestation, perinatal macrosomy in offspring from GDM-affected pregnancies and overt diabetes mellitus in women after GDM. MATERIAL AND METHODS. The study involved 146 women with GDM and 1806 women with normal carbohydrate metabolism during pregnancy, 506 newborns of gestational diabetic mothers and 993 newborns of healthy mothers, as well as 200 women with a history of GDM during the years 1990-1999 (the mean time period after GDM - 3.1 +/- 6.0 years). The recognized risk factors of GDM and perinatal macrosomy were evaluated, together with the incidence of overt diabetes mellitus after GDM-affected pregnancy.
An analysis of multifactor logistic regression demonstrated that the independent risk factors for GDM include: BMI 3 25 kg/m2 before pregnancy (OR - 2.38), the history of diabetes in family (OR - 1.67), and the third pr further pregnancy (OR - 1.81) - p < 0.05. In turn, experienced obstetric failures and delivery of child with macrosomy features revealed insignificant - p > 0.05. Perinatal macrosomy correlated with mother's BMI and glycaemia during the 2nd hour of diagnostic test (75 g OGTT). No correlations were observed among mother's age, fasting glycaemia levels and HbA1c in mothers. In the group of GDM-affected women, diabetes mellitus type 2 was diagnosed in 34 (17.0%) patients. The the actual BMI > 25 kg/m2 and glycaemia values in the 2nd hour of diagnostic test in the course of GDM diagnosis (p < 0.05). The risk of diabetes was not enhanced in that group of women by family history of diabetes, the age of GDM onset (< 25 years of life), the week of gestation when GDM was diagnosed (< 25 hbd), and the type of GDM therapy (insulin vs. diet) p > 0.05
Overweight and obesity are both risk factors of gestational diabetes mellitus, delivery of child with macrosomy features and of overt diabetes mellitus later in life.
妊娠期糖尿病(GDM)影响约5%的妊娠,导致剖宫产、围产期创伤和新生儿并发症的发生率增加。这些妊娠的新生儿中观察到巨大儿,即出生体重过重。在大多数情况下,妊娠终止后糖尿病会直接缓解,然而,在这些患者中的15%-60%,糖尿病会在晚年发病。本研究的目的是评估妊娠期GDM发生的危险因素、GDM妊娠后代的围产期巨大儿以及GDM后女性的显性糖尿病。材料与方法。该研究纳入了146例GDM女性和1806例孕期碳水化合物代谢正常的女性、506例妊娠期糖尿病母亲的新生儿和993例健康母亲的新生儿,以及1990-1999年有GDM病史的200例女性(GDM后的平均时间为3.1±6.0年)。评估了GDM和围产期巨大儿的公认危险因素,以及GDM妊娠后显性糖尿病的发生率。
多因素逻辑回归分析表明,GDM的独立危险因素包括:孕前BMI≥25kg/m²(OR-2.38)、家族糖尿病史(OR-1.67)以及第三次或更多次妊娠(OR-1.81)-p<0.05。相反,既往产科失败和分娩具有巨大儿特征的婴儿显示无统计学意义-p>0.05。围产期巨大儿与母亲的BMI以及诊断试验(75g口服葡萄糖耐量试验)第2小时的血糖相关。未观察到母亲年龄、空腹血糖水平和母亲糖化血红蛋白之间的相关性。在GDM女性组中,34例(17.0%)患者被诊断为2型糖尿病。GDM诊断过程中实际BMI>25kg/m²以及诊断试验第2小时的血糖值(p<0.05)。糖尿病家族史、GDM发病年龄(<25岁)、诊断GDM时的孕周(<25周)以及GDM治疗类型(胰岛素与饮食)在该组女性中并未增加糖尿病风险-p>0.05
超重和肥胖都是妊娠期糖尿病、分娩具有巨大儿特征的婴儿以及晚年显性糖尿病的危险因素。